Literature DB >> 11134183

An etiological role for aeroallergens and eosinophils in experimental esophagitis.

A Mishra1, S P Hogan, E B Brandt, M E Rothenberg.   

Abstract

Eosinophil infiltration into the esophagus is observed in diverse diseases including gastroesophageal reflux and allergic gastroenteritis, but the processes involved are largely unknown. We now report an original model of experimental esophagitis induced by exposure of mice to respiratory allergen. Allergen-challenged mice develop marked levels of esophageal eosinophils, free eosinophil granules, and epithelial cell hyperplasia, features that mimic the human disorders. Interestingly, exposure of mice to oral or intragastric allergen does not promote eosinophilic esophagitis, indicating that hypersensitivity in the esophagus occurs with simultaneous development of pulmonary inflammation. Furthermore, in the absence of eotaxin, eosinophil recruitment is attenuated, whereas in the absence of IL-5, eosinophil accumulation and epithelial hyperplasia are ablated. These results establish a pathophysiological connection between allergic hypersensitivity responses in the lung and esophagus and demonstrate an etiologic role for inhaled allergens and eosinophils in gastrointestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134183      PMCID: PMC198543          DOI: 10.1172/JCI10224

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Criteria of eosinophilia.

Authors:  G DISCOMBE
Journal:  Lancet       Date:  1946-02-09       Impact factor: 79.321

Review 2.  Summary and recommendations: Classification of gastrointestinal manifestations due to immunologic reactions to foods in infants and young children.

Authors:  H A Sampson; J A Anderson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000       Impact factor: 2.839

Review 3.  Eosinophilic gastroenteritis.

Authors:  K J Kelly
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000       Impact factor: 2.839

4.  Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids.

Authors:  C A Liacouras; W J Wenner; K Brown; E Ruchelli
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-04       Impact factor: 2.839

5.  Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation.

Authors:  B Lamkhioued; P M Renzi; S Abi-Younes; E A Garcia-Zepada; Z Allakhverdi; O Ghaffar; M D Rothenberg; A D Luster; Q Hamid
Journal:  J Immunol       Date:  1997-11-01       Impact factor: 5.422

6.  The epidemic of allergy and asthma.

Authors:  S T Holgate
Journal:  Nature       Date:  1999-11-25       Impact factor: 49.962

7.  The ABA-1 allergen of Ascaris lumbricoides: sequence polymorphism, stage and tissue-specific expression, lipid binding function, and protein biophysical properties.

Authors:  Y Xia; H J Spence; J Moore; N Heaney; L McDermott; A Cooper; D G Watson; B Mei; R Komuniecki; M W Kennedy
Journal:  Parasitology       Date:  2000-02       Impact factor: 3.234

8.  Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula.

Authors:  K J Kelly; A J Lazenby; P C Rowe; J H Yardley; J A Perman; H A Sampson
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

9.  Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia.

Authors:  M E Rothenberg; J A MacLean; E Pearlman; A D Luster; P Leder
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

10.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.

Authors:  P S Foster; S P Hogan; A J Ramsay; K I Matthaei; I G Young
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  194 in total

Review 1.  Epidemiology and Natural History of Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Ikuo Hirano
Journal:  Gastroenterology       Date:  2017-08-01       Impact factor: 22.682

2.  Involvement of mast cells in eosinophilic esophagitis.

Authors:  J Pablo Abonia; Carine Blanchard; Bridget Buckmeier Butz; Heather F Rainey; Margaret H Collins; Keith Stringer; Philip E Putnam; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

3.  Treatment options for eosinophilic esophagitis: elemental diet.

Authors:  Samer Gawrieh; Reza Shaker
Journal:  Curr Gastroenterol Rep       Date:  2004-06

4.  52-year-old woman with dysphagia.

Authors:  Sahil Khanna; Amit Noheria; Charles H Rohren
Journal:  Mayo Clin Proc       Date:  2010-08       Impact factor: 7.616

Review 5.  The Role of the Environment in Eosinophilic Esophagitis.

Authors:  Paul J Dowling; Hannah Neuhaus; Brooke I Polk
Journal:  Clin Rev Allergy Immunol       Date:  2019-12       Impact factor: 8.667

6.  Eosinophilic esophagitis: strictures, impactions, dysphagia.

Authors:  Seema Khan; Susan R Orenstein; Carlo Di Lorenzo; Samuel A Kocoshis; Philip E Putnam; Luther Sigurdsson; Theresa M Shalaby
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

7.  HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.

Authors:  Alejandro A Pezzulo; Rosarie A Tudas; Carley G Stewart; Luis G Vargas Buonfiglio; Brian D Lindsay; Peter J Taft; Nicholas D Gansemer; Joseph Zabner
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

8.  Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.

Authors:  Chang Zeng; Simone Vanoni; David Wu; Julie M Caldwell; Justin C Wheeler; Kavisha Arora; Taeko K Noah; Lisa Waggoner; John A Besse; Amnah N Yamani; Jazib Uddin; Mark Rochman; Ting Wen; Mirna Chehade; Margaret H Collins; Vincent A Mukkada; Philip E Putnam; Anjaparavanda P Naren; Marc E Rothenberg; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2018-05-04       Impact factor: 10.793

9.  Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses.

Authors:  C Blanchard; M K Mingler; M McBride; P E Putnam; M H Collins; G Chang; K Stringer; J P Abonia; J D Molkentin; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2008-05-07       Impact factor: 7.313

10.  Genetic and epigenetic underpinnings of eosinophilic esophagitis.

Authors:  Joseph D Sherrill; Marc E Rothenberg
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.